Abstract Background: In randomized controlled trials, add-on cannabidiol (CBD) has been shown to reduce seizure frequency in patients with Lennox-Gastaut…
Abstract Introduction: Effectiveness and tolerability of plant-derived highly purified cannabidiol (CBD) in patients with Lennox–Gastaut syndrome (LGS), Dravet syndrome (DS),…
Abstract Objective: Cannabidiol (CBD) is approved for treatment of Dravet syndrome (DS), Lennox‐Gastaut syndrome (LGS), and tuberous sclerosis complex (TSC).…
Abstract Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s40263-022-00955-9. Authors: Adam Strzelczyk ⚬, Susanne Schubert-Bast…
Abstract Graphical abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s40263-022-00898-1. Authors: Adam Strzelczyk ⚬, Susanne Schubert-Bast…
Abstract Tuberous sclerosis complex (TSC) is a rare genetic disorder caused by mutations in the TSC1 or TSC2 genes, which…
Abstract Lennox-Gastaut syndrome (LGS), a childhood-onset severe developmental and epileptic encephalopathy (DEE), is an entity that encompasses a heterogenous group…